In this article, we present a case of a patient with relapsed Hodgkin lymphoma who responded to salvage chemotherapy incorporating brentuximab vedotin, a novel agent.
GSK plc announced positive data from the ZOSTER-049 long-term follow-up phase III trial which followed participants for up to approximately 11 years following initial vaccination with Shingrix (Recombinant Zoster Vaccine or RZV)
Concise infographic summaries on early breast cancer stratification
60th Annual Meeting, European Association for the Study of Diabetes (EASD) , from September 10th - 13th 2024, in Madrid, Spain
UCB announced that the FDA has on 30 September 2013 approved Cimzia (certolizumab pegol) for the treatment of adult patients...
Recap on key HS highlights from EADV 2023 with expert Professor Falk Bechara
On 24 April each year, the Confederation of Meningitis Organisations (CoMO) lead a dedicated campaign to promote awareness of Meningitis.